These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2011124)

  • 1. Studies on the relationship between structure and IgE-binding ability of Parietaria judaica allergen I.
    Polo F; Ayuso R; Carreira J
    Mol Immunol; 1991; 28(1-2):169-75. PubMed ID: 2011124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation by mAb based affinity chromatography of two Par j I isoallergens. Comparison of their physicochemical, immunochemical and allergenic properties.
    Ayuso R; Carreira J; Lombardero M; Duffort O; Peris A; Basomba A; Polo F
    Mol Immunol; 1993 Oct; 30(15):1347-54. PubMed ID: 7694085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Par j 1 and Par j 2, the major allergens from Parietaria judaica pollen, have similar immunoglobulin E epitopes.
    Asturias JA; Gómez-Bayón N; Eseverri JL; Martínez A
    Clin Exp Allergy; 2003 Apr; 33(4):518-24. PubMed ID: 12680870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive monoclonal antibody-based enzyme-linked immunosorbent assay to quantify Parietaria judaica major allergens, Par j 1 and Par j 2.
    Arilla MC; González-Rioja R; Ibarrola I; Mir A; Monteseirín J; Conde J; Martínez A; Asturias JA
    Clin Exp Allergy; 2006 Jan; 36(1):87-93. PubMed ID: 16393270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and characterization of recombinant Par j 1 and Par j 2 resembling the allergenic epitopes of Parietaria judaica pollen.
    Dorofeeva Y; Colombo P; Blanca M; Mari A; Khanferyan R; Valenta R; Focke-Tejkl M
    Sci Rep; 2019 Oct; 9(1):15043. PubMed ID: 31636285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of the major allergen of several Parietaria pollens by an anti-Par 1 monoclonal antibody-based ELISA. Analysis of crossreactivity among purified Par j 1, Par o 1 and Par m 1 allergens.
    Ayuso R; Carreira J; Polo F
    Clin Exp Allergy; 1995 Oct; 25(10):993-9. PubMed ID: 8556571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC purification of the main allergen of Parietaria judaica pollen.
    Polo F; Ayuso R; Carreira J
    Mol Immunol; 1990 Feb; 27(2):151-7. PubMed ID: 2320010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
    García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
    J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assignment of disulphide bridges in Par j 2.0101, a major allergen of Parietaria judaica pollen.
    Amoresano A; Pucci P; Duro G; Colombo P; Costa MA; Izzo V; Lamba D; Geraci D
    Biol Chem; 2003 Aug; 384(8):1165-72. PubMed ID: 12974385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of carbohydrate moieties in cross-reactivity between different components of Parietaria judaica pollen extract.
    Mucci N; Liberatore P; Federico R; Forlani F; Di Felice G; Afferni C; Tinghino R; De Cesare F; Pini C
    Allergy; 1992 Aug; 47(4 Pt 2):424-30. PubMed ID: 1280917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of Par j I, the major allergen of Parietaria judaica pollen.
    Ayuso R; Polo F; Carreira J
    Mol Immunol; 1988 Jan; 25(1):49-56. PubMed ID: 3343972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, expression in E. coli and immunological characterization of Par j 3.0201, a Parietaria pollen profilin variant.
    Bonura A; Trapani A; Gulino L; Longo V; Valenta R; Asero R; Colombo P
    Mol Immunol; 2014 Feb; 57(2):220-5. PubMed ID: 24172226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens.
    González-Rioja R; Ferrer A; Arilla MC; Ibarrola I; Viguera AR; Andreu C; Martínez A; Asturias JA
    Clin Exp Allergy; 2007 Feb; 37(2):243-50. PubMed ID: 17250697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoallergenic variants of the Parietaria judaica major allergen Par j 1: a member of the non-specific lipid transfer protein plant family.
    Bonura A; Amoroso S; Locorotondo G; Di Felice G; Tinghino R; Geraci D; Colombo P
    Int Arch Allergy Immunol; 2001 Sep; 126(1):32-40. PubMed ID: 11641604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The allergens of Parietaria.
    Colombo P; Bonura A; Costa M; Izzo V; Passantino R; Locorotondo G; Amoroso S; Geraci D
    Int Arch Allergy Immunol; 2003 Mar; 130(3):173-9. PubMed ID: 12660421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of two cDNA clones coding for isoforms of the Parietaria judaica major allergen Par j 1.0101.
    Duro G; Colombo P; Assunta Costa M; Izzo V; Porcasi R; Di Fiore R; Locorotondo G; Cocchiara R; Geraci D
    Int Arch Allergy Immunol; 1997 Apr; 112(4):348-55. PubMed ID: 9104790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a dominant antigenic determinant of Par o I encoded by recombinant DNA.
    Scotto d'Abusco AS; De Santo C; Menna T; Coscia MR; Oreste U; Geller-Bernstein C; Ruffilli A
    Clin Exp Allergy; 1996 Feb; 26(2):223-31. PubMed ID: 8835131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of Par o I, major allergen of Parietaria officinalis pollen.
    Oreste U; Coscia MR; Scotto d'Abusco A; Santonastaso V; Ruffilli A
    Int Arch Allergy Appl Immunol; 1991; 96(1):19-27. PubMed ID: 1752693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
    González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
    J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.